Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.88%214.66M | 28.22%475.82M | 29.50%235.56M | 3.99%371.11M | 1.22%181.91M | 29.51%356.87M | 40.36%179.71M | 23.20%275.56M | 23.98%128.03M | 6.80%223.67M |
| Operating income | -8.88%214.66M | 28.22%475.82M | 29.50%235.56M | 3.99%371.11M | 1.22%181.91M | 29.51%356.87M | 40.36%179.71M | 23.20%275.56M | 23.98%128.03M | 6.80%223.67M |
| Cost of sales | 10.50%-169.73M | -26.74%-382.96M | -31.10%-189.64M | -7.83%-302.16M | -7.56%-144.66M | -36.35%-280.23M | -38.19%-134.48M | -20.43%-205.52M | -23.89%-97.32M | -9.73%-170.66M |
| Operating expenses | 10.50%-169.73M | -26.74%-382.96M | -31.10%-189.64M | -7.83%-302.16M | -7.56%-144.66M | -36.35%-280.23M | -38.19%-134.48M | -20.43%-205.52M | -23.89%-97.32M | -9.73%-170.66M |
| Gross profit | -2.18%44.92M | 34.69%92.86M | 23.28%45.92M | -10.04%68.94M | -17.64%37.25M | 9.41%76.64M | 47.25%45.23M | 32.12%70.04M | 24.26%30.71M | -1.66%53.01M |
| Administrative expenses | -19.81%-20.16M | -26.53%-41.21M | -30.82%-16.83M | 10.85%-32.57M | 29.20%-12.86M | -90.40%-36.53M | -88.96%-18.17M | -3.38%-19.19M | -18.93%-9.61M | 6.11%-18.56M |
| Impairment and provision | ---- | -380.61%-793K | ---- | 82.10%-165K | ---- | -254.70%-922K | 59.68%-100K | 218.72%596K | -306.56%-248K | -87.08%187K |
| -Other impairment is provision | ---- | -380.61%-793K | ---- | 82.10%-165K | ---- | -254.70%-922K | 59.68%-100K | 218.72%596K | -306.56%-248K | -87.08%187K |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -123.40%-3.91M | -6.92%-4.42M | 27.03%-1.75M | 6.47%-4.13M |
| Special items of operating profit | 21.51%1.33M | 1,010.63%5.95M | 286.27%1.1M | -84.57%536K | -75.22%284K | 120.65%3.47M | -35.94%1.15M | 74.31%1.57M | 130.84%1.79M | -60.01%903K |
| Operating profit | -13.57%26.09M | 54.61%56.81M | 22.38%30.19M | -13.86%36.75M | 1.98%24.67M | -12.24%42.66M | 15.80%24.19M | 54.74%48.61M | 39.76%20.89M | -6.03%31.41M |
| Financing cost | -16.61%-6.73M | -6.26%-13.01M | -2.25%-5.77M | -39.15%-12.25M | ---5.64M | ---8.8M | ---- | ---- | ---- | ---- |
| Share of profits of associates | -53.41%116K | 2,453.33%383K | 174.77%249K | -6.25%15K | -1,950.00%-333K | -72.41%16K | 112.00%18K | -42.00%58K | -476.92%-150K | 412.50%100K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.48%-544K |
| Earning before tax | -21.03%19.48M | 80.23%44.18M | 31.96%24.67M | -27.63%24.52M | -22.77%18.7M | -30.40%33.87M | 16.73%24.21M | 57.15%48.67M | 44.26%20.74M | 23.59%30.97M |
| Tax | 23.11%-3.21M | -105.83%-12.63M | -101.84%-4.18M | -405.43%-6.14M | 13.72%-2.07M | 132.67%2.01M | 20.57%-2.4M | -4.97%-6.15M | -160.71%-3.02M | -5.04%-5.86M |
| After-tax profit from continuing operations | -20.61%16.27M | 71.69%31.55M | 23.27%20.5M | -48.78%18.38M | -23.76%16.63M | -15.60%35.88M | 23.08%21.81M | 69.33%42.52M | 34.06%17.72M | 28.90%25.11M |
| Earning after tax | -20.61%16.27M | 71.69%31.55M | 23.27%20.5M | -48.78%18.38M | -23.76%16.63M | -15.60%35.88M | 23.08%21.81M | 69.33%42.52M | 34.06%17.72M | 28.90%25.11M |
| Minority profit | -99.13%11K | 16,275.00%1.94M | 694.84%1.27M | 91.18%-12K | -543.75%-213K | ---136K | --48K | ---- | ---- | ---- |
| Profit attributable to shareholders | -15.43%16.26M | 61.02%29.61M | 14.19%19.23M | -48.94%18.39M | -22.61%16.84M | -15.28%36.02M | 22.81%21.76M | 69.33%42.52M | 34.06%17.72M | 28.90%25.11M |
| Basic earnings per share | -15.05%0.0079 | 60.67%0.0143 | 14.81%0.0093 | -49.14%0.0089 | -23.58%0.0081 | -16.67%0.0175 | 19.10%0.0106 | 65.35%0.021 | 30.88%0.0089 | -2.31%0.0127 |
| Diluted earnings per share | -15.05%0.0079 | 60.67%0.0143 | 14.81%0.0093 | -49.14%0.0089 | -23.58%0.0081 | -16.67%0.0175 | 19.10%0.0106 | 65.35%0.021 | 30.88%0.0089 | -2.31%0.0127 |
| Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Kreston John & Gan | -- | Kreston John & Gan | -- | Mazars LLP, CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Mazars LLP, CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Mazars LLP, CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.